Filing Details
- Accession Number:
- 0001225208-13-024798
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-12-05 16:11:36
- Reporting Period:
- 2013-12-05
- Filing Date:
- 2013-12-05
- Accepted Time:
- 2013-12-05 16:11:36
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1385187 | Covidien Plc | COV | Surgical & Medical Instruments & Apparatus (3841) | 980624794 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1524435 | Michael Sgrignari | C/O Covidien 15 Hampshire Street Mansfield MA 02048 | Senior Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Acquisiton | 2013-12-05 | 6,440 | $42.39 | 34,725 | No | 4 | M | Direct | |
Ordinary Shares | Acquisiton | 2013-12-05 | 5,712 | $39.18 | 40,437 | No | 4 | M | Direct | |
Ordinary Shares | Acquisiton | 2013-12-05 | 5,265 | $43.44 | 45,702 | No | 4 | M | Direct | |
Ordinary Shares | Acquisiton | 2013-12-05 | 5,182 | $52.53 | 50,884 | No | 4 | M | Direct | |
Ordinary Shares | Acquisiton | 2013-12-05 | 678 | $49.48 | 51,562 | No | 4 | M | Direct | |
Ordinary Shares | Disposition | 2013-12-05 | 23,277 | $67.33 | 28,285 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2013-12-05 | 678 | $0.00 | 678 | $49.48 |
Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2013-12-05 | 5,265 | $0.00 | 5,265 | $43.44 |
Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2013-12-05 | 5,712 | $0.00 | 5,712 | $39.18 |
Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2013-12-05 | 6,440 | $0.00 | 6,440 | $42.39 |
Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2013-12-05 | 5,182 | $0.00 | 5,182 | $52.53 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
1,357 | 2021-06-30 | No | 4 | M | Direct | |
0 | 2019-11-30 | No | 4 | M | Direct | |
5,713 | 2020-11-30 | No | 4 | M | Direct | |
12,881 | 2021-11-30 | No | 4 | M | Direct | |
15,548 | 2022-12-02 | No | 4 | M | Direct |
Footnotes
- The price reported is the weighted average price. Shares were sold in multiple transactions at prices ranging from $67.32 to $67.37. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a securityholder of the Issuer, full information regarding the number of shares sold at each price.
- Adjusted in connection with the spin-off of Covidien's pharmaceuticals business.
- Options become exercisable in equal installments on each of the first, second, third and fourth anniversary of the grant date.